PGP and acute lymphoblastic leukemia: The new DOX-PMs-NPMBP nanoparticle system can significantly regulate the functional activity of P-gp, thus reducing the efflux of Rho123 mediated by drug pump P-gp in drug-resistant ALL cells (Figure 4).